HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Toledo-Pereyra II

hyperosmolar colloid solution of 520mOsm/l. for prolonged hypothermic storage of canine kidneys; contains K2HPO4, KH2PO4, dextrose

Also Known As:

TP II solution; TP-II; TP-II solution

Networked: 4 relevant articles (2 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Pharmaceutical Preparations
- Solutions: 41770
  - Hypertonic Solutions: 338
    - Toledo-Pereyra II: 4

Experts

1.	Ranieri, Girolamo: 1 article (06/2006)
2.	Ribatti, Domenico: 1 article (06/2006)
3.	Roccaro, Aldo Maria: 1 article (06/2006)
4.	Vacca, Angelo: 1 article (06/2006)
5.	Abiko, T: 1 article (01/2000)
6.	Nakatsubo, S: 1 article (01/2000)

Related Diseases

1.	Stroke (Strokes) 01/01/2022 - "The univariate and multivariate analyses revealed the following novel findings: (i) The incidence of unfavorable functional outcomes after non-CE was significantly greater (p < 0.01) in patients with higher age, aspartate aminotransferase (AST), the National Institutes of Health Stroke Scale (NIHSS) score, and depressed total protein (TP); (ii) We established a novel model and nomogram to predict stroke prognosis, in addition to the known factors (age and the NIHSS score). "
2.	Breast Neoplasms (Breast Cancer) 01/01/2023 - "Efficacy of Endocrine Therapy Plus Trastuzumab and Pertuzumab vs De-escalated Chemotherapy in Patients with Hormone Receptor-Positive/ERBB2-Positive Early Breast Cancer: The Neoadjuvant WSG-TP-II Randomized Clinical Trial."
3.	Neoplasms (Cancer) 06/01/2006 - "This review summarizes: (i) the biochemical and tissue expression of TP; (ii) the pharmacological profile of CAP as an anti-cancer compound and the central role of TP in its activation; (iii) the potential antiangiogenetic role of TP-activated CAP in tumours."
4.	Communicable Diseases (Infectious Diseases) 01/01/2000 - "The synthetic [1-Nal3] TP II, TP II and [Phe (4 F)3] TP II were tested for comparative effect on the impaired T-lymphocyte transformation by PHA in uremic patients suffering from recurrent infectious diseases. "

Related Drugs and Biologics

1.	Proteins (Proteins, Gene)
2.	Hormones (Hormone)
3.	Aspartate Aminotransferases (Aspartate Transaminase)
4.	Trastuzumab (Herceptin)
5.	pertuzumab

Related Therapies and Procedures

1.	Therapeutics
2.	Drug Therapy (Chemotherapy)